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Discussion
Dr S. Bert Litwin (Milwaukee, Wis). Dr Sano and his col-
leagues have presented data on 19 infants who underwent Nor-
wood palliation for HLHS, and they achieved an excellent 89%
hospital survival. Their surgical technique differs from that used
by most surgeons in the current era with pulmonary blood flow
received from a direct RV-PA shunt rather than a systemic–
pulmonary artery shunt.
Placing the pulmonary and systemic circulations in parallel
rather than in series may have certain advantages. Imbalance of
pulmonary and systemic blood flows is the leading cause of
morbidity and mortality after the Norwood procedure. Most cen-
ters accomplish balance by manipulating vascular resistance. Dr
Sano’s patients required no such manipulation, which resulted in a
more predictable postoperative recovery.
The pulmonary bed was not subjected to nor dependent on
diastolic flow, and there should be less change in pulmonary blood
flow with pulmonary hypertensive crises or during resuscitation in
the presence of low cardiac output or after a cardiac arrest.
There may, however, be deleterious effects with an additional
volume load on the ventricle from regurgitation through the
RV-PA shunt. This may result in ventricular dilatation and tricus-
pid regurgitation. A number of patients presented here had tricus-
pid regurgitation after stage I, although the incidence was less than
preoperatively.
Dr Sano used larger 4- and 5-mm shunts and achieved balanced
pulmonary and systemic circulations without overperfusion of the
lungs. With larger shunts, less precision in gauging the size of the
shunt should be needed and this might avoid some early reopera-
tions for shunt change. Also, with a larger shunt, there should be
a greater shunt longevity as well as a slower and more predictable
shunt closure pattern. Such was not the case here in that 2 patients
died late due to acute shunt closure and 7 others studied by
echocardiography showed progressive shunt narrowing within 4
months.
I have a few questions.
Did the shunt regurgitation cause an increase in tricuspid re-
gurgitation in any patient and did you have to repair the tricuspid
valve at stage II in any patient?
Why did you leave the shunt patent, as stated in your manu-
script, after stage II? Were the 2 deaths after stage II related to
residual shunt patency or tricuspid regurgitation? Did any patients
after stage II have prolonged pleural drainage?
In the manuscript you state that your survival was 53% before
you used the RV-PA shunt and 89% with the RV-PA shunt. Did
you analyze the two groups for other factors that might have
accounted for your improved survival?
Dr Sano, your presentation was clear, your manuscript was well
written, and you have made a compelling argument for the use of
the RV-PA shunt in the Norwood procedure. This information
should be useful to surgeons in considering various options for
babies with HLHS, and I thank you for bringing this information
to this meeting.
Dr Sano. Thank you, Dr Litwin, for your comments.
Regarding your first question, we also were concerned about
volume loading due to shunt regurgitation through a nonvalved
conduit. This was also why we used a 4-mm PTFE graft rather than
a 5-mm graft initially.
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However, we found that the regurgitant flow was not as much
as we expected. Rather than volume loading, we found that the
4-mm graft became stenotic very quickly. Therefore, we lost 2
patients out of 5 who had a 4-mm PTFE graft.
As I presented, regurgitant flow was 28% 2 weeks postopera-
tively, and this gradually decreased to 16% 4 months postopera-
tively. Tricuspid valve repair due to dilatation of the ventricle was
not necessary.
Regarding the second question, I left the shunt open because at
the time of BDG, the graft itself became smaller with some
forward flow to the pulmonary artery, especially to the left. There-
fore, saturation is little, but higher than that of a usual BDG and the
left PA grows more. This is also the advantage of the RV-PA
shunt.
Dr Litwin. In your manuscript you stated that your mortality
statistics were much improved with the RV-PA shunt as compared
with results in the previous patients. I wondered whether you
looked at other factors that might have accounted for improved
survival other than the use of the RV-PA shunt?
Dr Sano. Before 1998, I was doing the classic Norwood
procedure with a mortality of 50%. Achievement of the Fontan
procedure in the patients who underwent the classic Norwood was
less than 30%.
One big change during the initial period was to adopt cerebral
and myocardial perfusion to avoid deep hypothermia and circula-
tory arrest, stated in 1995. However, I think the result was not
different from and after 1995. A dramatic change has occurred
since 1998, when we started using the RV-PA shunt as a first
palliation for HLHS.
Dr Constantine Mavroudis. Dr Sano, why was there a differ-
ence?
Dr Sano. Because diastolic pressure was higher after the
RV-PA shunt Norwood. Also, in the classic Norwood, it is not
easy to make a balance between systemic and pulmonary circula-
tion. Also, I think that if diastolic pressure is high, coronary
perfusion should be better.
Dr Litwin. What was the cause of the 2 deaths after stage II?
Dr Sano. One was viral pneumonia and the other was due to
progressive hyopxemia.
Mr Marco Pozzi (Liverpool, United Kingdom). Over the past
6 months I have also introduced this technique into my experience
and it has made a dramatic difference. I parallel his experience. We
have had no mortality since we introduced this technique. In
particular, the management of the patient has become much sim-
pler. Indeed, our major problem in terms of mortality after the
Norwood operation was often due to postoperative mismanage-
ment. As with this technique, management has become simple. We
find that we do not require any more the degree of expertise.
The other important issue was the concern from the cardiolo-
gist’s point of view that introducing a ventriculotomy could have
affected the long-term result. However, so far all the echocardio-
graphic investigation on this patient would suggest that ventricular
function is absolutely indistinguishable from any other good pa-
tient after a classic type of Norwood repair. I certainly parallel Dr
Sano’s experience and confirm the validity of this technique.
Dr Christian Pizarro (Wilmington, Del). We have had similar
experience, which currently includes 34 patients with only 3
deaths. At this time, 18 patients have completed a second stage and
there has been no interstage mortality.
I just have one question. Have you used this new procedure for
patients with morphologic single left ventricle? If so, have you had
any trouble with the inflow into the shunt due to muscle growth
over time?
Dr Sano. Yes, in 1 patient. I could not find any good place to
do a ventriculotomy due to the ventricular septum, so I did a
classic Norwood.
Dr Francois Lacour-Gayet (Hamburg, Germany). I consider
this an important innovation. Since I have used this technique in
the last 5 patients, I have seen a totally different postoperative
course. As a matter of fact, you can reproduce this beneficial effect
in doing an RV-PA anastomosis in pulmonary atresia and ventric-
ular septal defect. This is a similar physiology and this shunt works
the same way.
I would like to comment a bit more on the second quality of this
anastomosis. I think this technique may solve the problem of the
left pulmonary artery in the Norwood procedure. There are a
number of publications showing that the left pulmonary artery is
sometimes hypoplastic. In a classic Norwood operation, the left
pulmonary artery has a tendency to go back in the posterior part of
the pericardium. Your shunt has the advantage to hold it. I have
recently done a Glenn anastomosis after an RV-PA shunt. On the
angiogram, I was very happy to see that the left pulmonary artery
was even bigger than the right, and I think that this is a big change.
I have one last question. What do you think about valvulation
of the shunt in the future?
Dr Sano. Dr Norwood performed the RV-PA shunt using a
valved conduit; however, the graft was too big at that time and
there was no survival. Theoretically, it is better to have a valve in
the RV-PA graft; however, it should be the same or similar size of
5-mm PTFE graft. If there is such an ideal graft with a valve, I will
certainly try to use it.
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